Skip to content
DataLookout
Menu

NOTICENCT04140344

The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 31 days later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 23 versions: 21 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 14 words Show 4 more changesShow less
    • Primary completion pushed from Oct 2026 to Dec 2026
    • Study completion pushed from Oct 2027 to Dec 2027
    • Secondary endpoints: details revised at 2 of 3 entries
    • Site contact updated
  2. Notable Primary completion date: Oct 2025 to Oct 2026
    • Study completion date: Oct 2026 to Oct 2027
    v21
  3. Notable Primary completion date: Oct 2024 to Oct 2025
    • Study completion date: Oct 2024 to Oct 2026
    v20
  4. Notable Trial status: Not Yet Recruiting to Recruitingv18 Show 4 more changesShow less
    • Enrollment target: 448 to 224
    • Start date changed from estimate of Oct 1, 2023 to Sep 7, 2023
    • Study description revised
    • Site details revised
  5. Notable Start date: Jun 1, 2023 to Oct 1, 2023
    • Primary and study completion dates: Jun 2024 to Oct 2024
    v17
Show 15 earlier versionsHide 15 earlier versions
  1. Notable Start date: Apr 1, 2023 to Jun 1, 2023v16 Show 4 more changesShow less
    • Primary endpoint revised
    • Primary and study completion dates: Apr 2024 to Jun 2024
    • Secondary endpoints revised (3)
    • Site contact updated
  2. Notable Start date: Feb 1, 2023 to Apr 1, 2023
    • Primary and study completion dates: Feb 2024 to Apr 2024
    v15
  3. Notable Start date: Nov 1, 2022 to Feb 1, 2023v14
  4. Notable Start date: Sep 1, 2022 to Nov 1, 2022v13
  5. Notable Start date: Jul 1, 2022 to Sep 1, 2022v12
  6. Notable Start date: Apr 1, 2022 to Jul 1, 2022v11
  7. Notable Start date: Jan 22, 2022 to Apr 1, 2022v10
  8. Notable Primary and study completion dates: Feb 2023 to Feb 2024
    • Start date: Nov 22, 2021 to Jan 22, 2022
    v9
  9. Notable Start date: Oct 16, 2021 to Nov 22, 2021v8
  10. Notable Start date: Aug 16, 2021 to Oct 16, 2021v7
  11. Notable Start date: Jul 1, 2021 to Aug 16, 2021v6
  12. Notable Start date: Apr 2021 to Jul 1, 2021v5
  13. Notable Start date: Jan 2021 to Apr 2021v4
  14. Notable Start date: Apr 2020 to Jan 2021v3
  15. Notable Start date: Jan 2020 to Apr 2020
    • Secondary endpoints revised (3)
    v2
  1. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in readmission rates within 30 days post-lumbar spine surgery.
Timeframe: Baseline, 30 days

Secondary (3)

Change in Emergency Department (ED) visit rates within 30 days post-lumbar spine surgery.
Change in back and leg pain levels within 30 days post-lumbar spine surgery as measured by "Oswestry Disability Index" (ODI) questionnaire.
Change in anxiety/depression levels within 30 days post-lumbar spine surgery as measured by "European Quality of Life-5 Dimension" (EQ-5D) questionnaire.

Arms and interventions

ARM 1: Text Message GroupExperimental

The intervention group will receive automated text messages every day for the first week, and every other day for the second week post-operatively. The text messages will follow a series of pre-defined standardized scripts (Appendix 3) with embedded hyperlinks to a video from the providers with further advice. The patient is directed not to respond to the text messages, but to call for any questions or concerns. The text message group will receive a 30-day post-operative phone call to evaluate: number of ED visits, hospital readmissions, and to re-administer the questionnaires completed at baseline visit. Other data to be collected may include the following: number of phone calls to provider, MyChart messages to provider, pain medications, and new problems like pain and infection.

ARM 2: Control groupNo intervention

The control group will be given the standard post-op packet that includes detailed instructions on proper wound care and signs and symptoms of infection. They will not receive text messages. The same outcomes will be assessed in both groups through a 30-day post-operative phone call.

Other: Text Message Group

Sites

1 site in 1 country

  • Duke Neurosurgery and Duke OrthopedicsDurham, North Carolina, United States